drugset
drugset / Trial / NCT04431778

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

NCT04431778 ↗

Phase 2 Unknown 64 enrolled University Hospital, Clermont-Ferrand
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluation of the efficacy and tolerance of low doses of ethosuximide in the treatment of peripheral neuropathic pain

Timeline

Start
2020-11-01
Primary completion
2023-11-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ethosuximide Small molecule 500 mg —

Indications

neuropathy, painful